JGHHY yields 3.78% · JNJ yields 2.13%● Live data
📍 JGHHY pulled ahead of the other in Year 1
Combined, JGHHY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JGHHY + JNJ for your $10,000?
Jungheinrich Aktiengesellschaft, through its subsidiaries, manufactures and supplies products and solutions in the fields of warehousing and material handling equipment, automated systems, digital solutions, and matching services worldwide. It operates through Intralogistics and Financial Services segments. The Intralogistics segment develops, produces, sells, and rents new material handling equipment and warehousing equipment products; sale and short-term leasing of used trucks; and provides spare parts, as well as maintenance and repair services. The Financial Services segment engages in the sales financing and usage transfer of material handling and warehousing equipment products. The company's products portfolio includes pedestrian trucks, horizontal and vertical level order pickers, narrow aisle trucks, automated guided vehicles, stacker cranes, load handling equipment, reach trucks, stackers, tow tractors, low lift and double decker trucks, and electric drive trains, as well as pallet trucks; counterbalanced trucks; small-series and customized trucks; powertrain solutions; and electronic control units, lithium-ion batteries, and chargers. It also develops and distributes warehouse and fleet management systems, steering softwares for conveyor systems, and other digital solutions, as well as automation systems; and develops software solutions. The company distributes its products through its direct sales and service network, as well as through dealers. Jungheinrich Aktiengesellschaft was founded in 1953 and is headquartered in Hamburg, Germany.
Full JGHHY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.